Current Landscape of Immunotherapy in Breast CancerSylvia Adams, Elizabeth A. Mittendorf, Larissa A. Korde et al.|JAMA Oncology|2019Cited by 409
AKT in cancer: new molecular insights and advances in drug developmentPrabhjot S. Mundi, Kevin Kalinsky, Jasgit C. Sachdev et al.|British Journal of Clinical Pharmacology|2016Cited by 267
Inavolisib-Based Therapy in <i>PIK3CA</i> -Mutated Advanced Breast CancerNicholas C. Turner, Komal Jhaveri, Cristina Saura et al.|New England Journal of Medicine|2024Cited by 235
Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline UpdateN. Lynn Henry, Angela DeMichele, Zoneddy Dayao et al.|Journal of Clinical Oncology|2022Cited by 127
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG‐ACRIN Cancer Research Group (E2607)Kevin Kalinsky, John M. Kirkwood, Krista M. Rubin et al.|Cancer|2017Cited by 125